Skip to main content
search

Publications

Sign up

Featured publication

Population Pharmacokinetics of Clesrovimabin Preterm and Full-Term Infants
Population Pharmacokinetics of Clesrovimabin Preterm and Full-Term Infants

Population Pharmacokinetics of Clesrovimabin Preterm and Full-Term Infants

This study, published in Clinical Pharmacology & Therapeutics (CPT), shows how population pharmacokinetic modeling supports a single, once-per-season dose of clesrovimab for respiratory syncytial…

Latest publications

Popular publications

A Tutorial on the Development of a Physiologically Inspired PKRO Model for Monoclonal Antibodies
A Tutorial on the Development of a Physiologically Inspired PKRO Model for Monoclonal Antibodies

A Tutorial on the Development of a Physiologically Inspired PKRO Model for Monoclonal Antibodies

History and Evolution of Innovations in Clinical Pharmacology
History and Evolution of Innovations in Clinical Pharmacology

History and Evolution of Innovations in Clinical Pharmacology

Modeling amyloid plaque turnover dynamics improves characterization of drug effects
Modeling amyloid plaque turnover dynamics improves characterization of drug effects

Modeling amyloid plaque turnover dynamics improves characterization of drug effects

Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges
Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges

Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges

Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema
Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema

Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema

Towards new approach methodologies for biological therapeutics: a novel model-informed metric to assess immunogenicity risk
Towards new approach methodologies for biological therapeutics: a novel model-informed metric to assess immunogenicity risk

Towards new approach methodologies for biological therapeutics: a novel model-informed metric to assess immunogenicity risk

Collection
Simcyp Publications and Independent Applications

We are proud to share our publications by the Simcyp R&D Team (1997 – Present) and independent applications of Simcyp by industry, academia, and regulatory organizations (2007 – Present).

Learn more

All publications

Population Pharmacokinetics of Clesrovimabin Preterm and Full-Term Infants

Publication Biologics Certara Services Clinical Pharmacology Clinical Trials Drug Development Infectious Disease Model Informed Drug Development Modeling and Simulation Modeling and Simulation - PK/PD Pediatrics Therapeutic Specialties

Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis Patients

Publication Certara Services Clinical Pharmacology Clinical Trials Drug Development Model Informed Drug Development Model-Based Meta-Analysis (MBMA) Modeling and Simulation Therapeutic Specialties

Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development

Publication Certara Services Drug Development Model Informed Drug Development Modeling and Simulation Modeling and Simulation - QSP

A Systematic Review and Model-Based Meta-Analysis of Pegylated-Interferon-α-Induced HBsAg Loss in Chronic Hepatitis B Virus Infection

Publication Certara Services Clinical Pharmacology Clinical Trials Drug Development Drug Safety Model Informed Drug Development Model-Based Meta-Analysis (MBMA) Modeling and Simulation

A Tutorial on the Development of a Physiologically Inspired PKRO Model for Monoclonal Antibodies

Publication Modeling and Simulation - QSP

History and Evolution of Innovations in Clinical Pharmacology

Publication Clinical Pharmacology Model Informed Drug Development Modeling and Simulation

Modeling amyloid plaque turnover dynamics improves characterization of drug effects

Publication Biologics Central Nervous System (CNS) Clinical Pharmacology Drug Development Model Informed Drug Development Modeling and Simulation Modeling and Simulation - QSP

Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges

Publication Certara Products - Simcyp Clinical Pharmacology Model Informed Drug Development Modeling and Simulation - PBPK

Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema

Publication Certara Services Clinical Pharmacology Drug Development Model Informed Drug Development Modeling and Simulation - PK/PD Pharmacometrics Rare and Neglected Diseases Therapeutic Specialties
Be the first to get the latest

Transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.